The CXCR4 antagonist AMD3100 mobilizes a more primitive subset of CD34+cells than G-CSF

被引：0
|
作者：
Seeger, T
Veldwijk, M
Bridger, G
Calandra, G
Goldschmidt, H
Ho, A
Fruehauf, S
机构：
[1] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[2] German Canc Res Ctr, Dept E0120, D-6900 Heidelberg, Germany
[3] AnorMED, Langley, BC, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.1969.1969
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1969
引用
收藏
页码：558A / 558A
页数：1
相关论文
共 50 条
  • [11] Potential clinical applications of the CXCR4 antagonist bicyclam AMD3100
    De Clercq, E
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 805 - 824
  • [12] Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist
    Liles, WC
    Broxmeyer, HE
    Rodger, E
    Wood, B
    Hübel, K
    Cooper, S
    Hangoc, G
    Bridger, GJ
    Henson, GW
    Calandra, G
    Dale, DC
    BLOOD, 2003, 102 (08) : 2728 - 2730
  • [13] THE PROTEIN EPITOPE MIMETIC (PEM) CXCR4 ANTAGONIST POL5551 MOBILIZES HEMATOPOIETIC STEM AND PROGENITOR CELLS WITH GREATER EFFICIENCY THAN AMD3100, SYNERGIZES WITH G-CSF, AND MOBILIZED CELLS DEMONSTRATE FAVORABLE TRANSPLANTATION PROPERTIES
    Karpova, D.
    Dauber, K.
    Spohn, G.
    Chudziak, D.
    Romagnoli, B.
    Patel, K.
    Chevalier, E.
    Bonig, H.
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : S15 - S16
  • [14] CHARACTERIZATION OF CD34 POSITIVE STEM CELLS IN HAEMATOLOGICAL PATIENTS MOBILIZED WITH G-CSF AND AMD3100
    Giancola, Raffaella
    Accorsi, Patrizia
    Catinella, Virginia
    Passeri, Cecilia
    Michetti, Noemi
    Contento, Alessandro
    Di Riti, Maria
    Iacone, Antonio
    EXPERIMENTAL HEMATOLOGY, 2012, 40 (08) : S153 - S154
  • [15] The CXCR4 Antagonist AMD3100 Impairs Survival of AML Cells and Induces Their Differentiation
    Tavor, Sigal
    Eisenbach, Manny
    Jacob-Hirsch, Jasmine
    Golan, Tammar
    Petit, Isabelle
    Ben-Zion, Katz
    Kay, Sigi
    Baron, Shoshana
    Amariglio, Ninette
    Deutsch, Varda
    Naparstek, Elizabeth
    Rechavi, Gideon
    BLOOD, 2008, 112 (11) : 573 - 573
  • [16] Enhancement of G-CSF mobilization of human BM CD34+ cells with AMD3100: Substantial increase in the frequency of repopulating cells through tandem administration of G-CSF and AMD3100.
    Srour, EF
    Plett, AP
    Dale, DC
    Liles, C
    Calandra, GB
    Orschell, CM
    BLOOD, 2003, 102 (11) : 455A - 455A
  • [17] CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
    Wang, Jingzhe
    Tannous, Bakhos A.
    Poznansky, Mark C.
    Chen, Huabiao
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [18] The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
    Tavor, S.
    Eisenbach, M.
    Jacob-Hirsch, J.
    Golan, T.
    Petit, I.
    BenZion, K.
    Kay, S.
    Baron, S.
    Amariglio, N.
    Deutsch, V.
    Naparstek, E.
    Rechavi, G.
    LEUKEMIA, 2008, 22 (12) : 2151 - 2158
  • [19] The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation
    S Tavor
    M Eisenbach
    J Jacob-Hirsch
    T Golan
    I Petit
    K BenZion
    S Kay
    S Baron
    N Amariglio
    V Deutsch
    E Naparstek
    G Rechavi
    Leukemia, 2008, 22 : 2151 - 2158
  • [20] Mobilization and collection of CD34+progenitor cells from normal human volunteers with AMD-3100, a CXCR4 antagonist, and G-CSF.
    Liles, WC
    Rodger, E
    Broxmeyer, HE
    Srour, EF
    Dehner, C
    Badel, K
    Calandra, G
    Christensen, J
    Wood, B
    Price, TH
    Dale, DC
    BLOOD, 2002, 100 (11) : 109A - 109A
12345